✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Rossari Biotech Ltd.

ROSSARI

Market Cap
₹3,667 Cr.
P/E
26.89

Rossari Biotech Ltd.

  • Rossari Biotech
  • SH Kelkar & Co
  • Oriental Aromatics
FAQs on Rossari Biotech Ltd. Shareprice

Rossari Biotech has given lower returns compared to its competitors.
Rossari Biotech has grown at ~-6.68% over the last 3yrs while peers have grown at a median rate of -2.77%

Rossari Biotech is not expensive.
Latest PE of Rossari Biotech is 27.53, while 3 year average PE is 48.72.
Also latest EV/EBITDA of Rossari Biotech is 14.66 while 3yr average is 26.45.

View FAQ's On Business
Growth Table
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Balance Sheet
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Cash Flow
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Quarterly Results
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Rossari Biotech Ltd. Financials

Balance sheet of Rossari Biotech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Rossari Biotech is increasing.
Latest net debt of Rossari Biotech is ₹74.55 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹45.81 Crs.

Yes, profit is increasing.
The profit of Rossari Biotech is ₹136 Crs for Mar 2025, ₹131 Crs for Mar 2024 and ₹107 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rossari Biotech latest dividend payout ratio is 2.03% and 3yr average dividend payout ratio is 2.24%

NA

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech